Can you provide information regarding the merger of Caremark Rx with AdvancePCS along with cost-basis information?
Under the terms of the merger agreement, entered into on September 2, 2003, Caremark Rx acquired 100 percent of AdvancePCS’s outstanding stock. AdvancePCS stockholders received value equivalent to 2.15 shares of Caremark Rx common stock for each AdvancePCS share, were paid 90% in Caremark Rx common stock and 10% in cash. For each share of AdvancePCS common stock held, AdvancePCS stockholders received: • shares of Caremark Rx common stock in an amount equal to the product of (1) 2.15 and 0.90, or 1.935 shares of Caremark Rx common stock; and • an amount in cash equal to 0.10 multiplied by the product of (1) 2.15 and (2) the average of the per share closing sales prices of shares of Caremark Rx common stock as reported on the NYSE during the five consecutive trading day period ending on, and including, the fifth trading day immediately prior to the effective time of the merger. Based on this pricing period, the resulting amount of cash received for each AdvancePCS share held was $7.01. S
Related Questions
- Can you provide information regarding the merger of Caremark Rx with CVS Corporation along with cost-basis information?
- Can you provide information regarding the merger of Caremark Rx with MedPartners along with cost-basis information?
- Can you provide information regarding the merger of Caremark Rx with AdvancePCS along with cost-basis information?
